Strata Critical Medical (SRTA) Stock Statistics & Valuation Metrics

Strata Critical Medical has a market cap or net worth of $394.93M. The enterprise value is $364.44M.

Strata Critical Medical has 86,989,140 shares outstanding. The number of shares has decreased by -2.65% in one year.

Strata Critical Medical’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 15.04%.

The current PE Ratio of Strata Critical Medical is 9.6. Strata Critical Medical’s PEG ratio is -0.04.

In the last 12 months, Strata Critical Medical had revenue of 197.14M and earned 41.35M in profits. Earnings per share was 0.50.

In the last 12 months, operating cash flow was -48.91M and capital expenditures -10.85M, giving a free cash flow of -59.77M billion.

Strata Critical Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Strata Critical Medical upcoming earnings date is May 12, 2026, After Close (Confirmed).

Strata Critical Medical as a current ratio of 6.38, with Debt / Equity ratio of 1.18%

In the past 12 months, Strata Critical Medical has paid -61.41M in taxes.

Strata Critical Medical EV to EBITDA ratio is -31.05, with an EV/FCF ratio of -6.31.

Strata Critical Medical has $61.23M in cash and marketable securities with $3.31M in debt, giving a net cash position of $57.92M billion.

Gross margin is 20.86%, with operating margin of -11.34%, and net profit margin of 20.97%.

The average price target for Strata Critical Medical is $9.63, which is 11.43% higher than the current price. The consensus rating is Moderate Buy